Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation

Journal of Virology

Volumn 87, Issue 1, 2013, Pages 474-481

  Kopp, Sarah J ^a   Karaba, Andrew H ^a   Cohen, Laura K ^a   Banisadr, Ghazal ^a   Miller, Richard J ^a   Muller, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VIRUS RECEPTOR; NECTIN 1; NEURON SPECIFIC NUCLEAR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENOTYPE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MORTALITY; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NEWBORN; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ATTENUATION; VIRUS PATHOGENESIS; WILD TYPE;

ANIMALS; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, VIRUS; SURVIVAL ANALYSIS;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 2; MUS; SIMPLEXVIRUS;

EID: 84871992697     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01849-12     Document Type: Article

References (36)

1. Thompson C, Whitley R. 2011. Neonatal herpes simplex virus infections: where are we now? Adv. Exp. Med. Biol. 697:221-230.
2. Kimberlin DW. 2004. Neonatal herpes simplex infection. Clin. Microbiol. Rev. 17:1-13.
3. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ. 2001. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108:223-229.
4. Schiffer JT, Corey L. 2009. Herpes simplex virus. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th ed, p 1943-1962. Churchill Livingstone, Philadelphia, PA.
5. Muller WJ, Jones CA, Koelle DM. 2010. Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr. Immunol. Rev. 6:18.
6. Spear PG. 2004. Herpes simplex virus: receptors and ligands for cell entry. Cell. Microbiol. 6:401-410.
7. Spear PG, Eisenberg RJ, Cohen GH. 2000. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275:1-8.
8. Lopez M, Cocchi F, Menotti L, Avitabile E, Dubreuil P, Campadelli-Fiume G. 2000. Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 74:1267-1274.
9. Shukla D, Liu J, Blaiklock P, Shworak N, Bai X, Esko J, Cohen G, Eisenberg R, Rosenberg R, Spear P. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13-22.
10. Taylor JM, Lin E, Susmarski N, Yoon M, Zago A, Ware CF, Pfeffer K, Miyoshi J, Takai Y, Spear PG. 2007. Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2:19-28.
11. Kopp SJ, Banisadr G, Glajch K, Maurer UE, Grunewald K, Miller RJ, Osten P, Spear PG. 2009. Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc. Natl. Acad. Sci. U. S. A. 106:17916-17920.
12. Karaba AH, Kopp SJ, Longnecker R. 2011. Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. J. Virol. 85:10041-10047.
13. Westmoreland D, Rapp F. 1976. Host range temperature-sensitive mutants of herpes simplex virus type 2. J. Virol. 18:92-102.
14. Yoon M, Kopp SJ, Taylor JM, Storti CS, Spear PG, Muller WJ. 2011. Functional interaction between herpes simplex virus type 2 gD andHVEM transiently dampens local chemokine production after murine mucosal infection. PLoS One 6:e16122. doi:10.1371/journal.pone.0016122.
15. Adkins B, Leclerc C, Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564.
16. Corey L, Wald A. 2009. Maternal and neonatal herpes simplex virus infections. N. Engl. J. Med. 361:1376-1385.
17. Maness PF, Schachner M. 2007. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat. Neurosci. 10:19-26.
18. Moore R, Larue L. 2004. Cell surface molecules and truncal neural crest ontogeny: a perspective. Birth Defects Res. C Embryo Today 72:140-150.
19. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178.
20. Cecconi F, Di Bartolomeo S, Nardacci R, Fuoco C, Corazzari M, Giunta L, Romagnoli A, Stoykova A, Chowdhury K, Fimia GM, Piacentini M. 2007. A novel role for autophagy in neurodevelopment. Autophagy 3:506-508.
21. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
22. Ahmed M, Lock M, Miller CG, Fraser NW. 2002. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J. Virol. 76:717-729.
23. Perkins D, Pereira EF, Gober M, Yarowsky PJ, Aurelian L. 2002. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 76:1435-1449.
24. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174:2220-2227.
25. Jones CA, Fernandez M, Herc K, Bosnjak L, Miranda-Saksena M, Boadle RA, Cunningham A. 2003. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J. Virol. 77:11139-11149.
26. Cuchet-Lourenço D, Boutell C, Lukashchuk V, Grant K, Sykes A, Murray J, Orr A, Everett RD. 2011. SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog. 7:e1002123. doi:10.1371/journal.ppat.1002123.
27. Kempermann G, Jessberger S, Steiner B, Kronenberg G. 2004. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 27:447-452.
28. Kimoto H, Eto R, Abe M, Kato H, Araki T. 2009. Alterations of glial cells in the mouse hippocampus during postnatal development. Cell. Mol. Neurobiol. 29:1181-1189.
29. Sedý J, Spear P, Ware C. 2008. Cross-regulation between herpesviruses and the TNF superfamily members. Nat. Rev. Immunol. 8:861-873.
30. Kopp SJ, Storti CS, Muller WJ. 2012. Herpes simplex virus-2 glycopro-tein interaction with HVEM influences virus-specific recall cellular responses at the mucosa. Clin. Dev. Immunol. doi:10.1155/2012/284104.
31. Wu Y, Navarro F, Lal A, Basar E, Pandey RK, Manoharan M, Feng Y, Lee SJ, Lieberman J, Palliser D. 2009. Durable protection from herpes simplex virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene. Cell Host Microbe 5:84-94.
32. Diamond C, Mohan K, Hobson A, Frenkel L, Corey L. 1999. Viremia in neonatal herpes simplex virus infections. Pediatr. Infect. Dis. J. 18:487-489.
33. Kimura H, Futamura M, Kito H, Ando T, Goto M, Kuzushima K, Shibata M, Morishima T. 1991. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 164:289-293.
34. Malm G, Forsgren M. 1999. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch. Dis. Child. Fetal Neonatal Ed. 81:F24-F29.
35. Kern ER, Overall JC, Jr, Glasgow LA. 1973. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J. Infect. Dis. 128:290-299.
36. Kern ER, Richards JT, Overall JC, Jr. 1986. Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis. Antiviral Res. 6:189-195.